Obesity Clinical Trial
— LABS3Official title:
Psychosocial Issues and Bariatric Surgery
NCT number | NCT02495142 |
Other study ID # | 5R01DK084979-06 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 2010 |
Est. completion date | June 30, 2019 |
Verified date | August 2019 |
Source | Neuropsychiatric Research Institute, Fargo, North Dakota |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Bariatric surgery is associated with long-term weight loss, as well as short-term
improvements in obesity-related medical comorbidities. However, a significant proportion of
patients fail to lose sufficient weight, or experience significant weight regain. Although no
robust predictors of response have been identified, pilot data that will be presented and
reviewed suggest that surgery has profound effects on eating behaviors and psychosocial
functioning, and that these factors may affect postoperative weight control.
The present investigation capitalizes on the Longitudinal Assessment of Bariatric Surgery
(LABS) consortium to conduct an in-depth examination of the psychosocial aspects of surgery
among a geographically, ethnically, and racially diverse sample of men and women undergoing
bariatric surgery. This project unites experts in the areas of psychopathology, eating
behaviors and quality of life to conduct a naturalistic study using state-of-the-art
assessment tools; to document the relationships among psychosocial factors; and to examine
psychosocial predictors of surgical outcomes.
Status | Completed |
Enrollment | 202 |
Est. completion date | June 30, 2019 |
Est. primary completion date | June 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male and female patients who are at least 18 years of age and undergo bariatric surgery by a LABS certified surgeon. - Previous enrollment in LABS-1 and LABS-2. - BMI at baseline of greater than or equal to 35. Exclusion Criteria: - Informed consent not obtained - Type 1 Diabetes Mellitus - Unlikely to comply with follow-up protocol (ie: geographically inaccessible for study visits) - Unable to communicate with local study staff |
Country | Name | City | State |
---|---|---|---|
United States | Neuropsychiatric Research Institute | Fargo | North Dakota |
Lead Sponsor | Collaborator |
---|---|
Neuropsychiatric Research Institute, Fargo, North Dakota | Columbia University, Duquesne University, University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Affect regulation as measured by the DERS | Difficulties in Emotion Regulation Scale: The DERS is a 36-item self-report questionnaire that assesses six domains of emotion dysregulation and has been found to have acceptable internal consistency as well as adequate test-retest reliability and construct validity. | 7 year post bariatric surgery | |
Other | Affect regulation as measured by the AIM | Affect Intensity Measure:The AIM is a 40-item self-report measure of positive and negative emotional intensity and reactivity. | 7 years post bariatric surgery | |
Other | Impulsivity | UPPS-P Impulsive Behavior Scale: This is a 59-item self-report measure assessing five dimensions of impulsivity. Only the negative urgency and positive urgency subscales will be administered. | 7 years post bariatric surgery | |
Other | Behavioral inhibition as measured by the SPSRQ | Sensitivity to Punishment and Sensitivity to Reward Questionnaire: This is a 44-item self-report measure that is based on Gray's behavioral inhibition and activation motivational systems conceptualization, and assesses sensitivity to punishment and reward. | 7 years post bariatric surgery | |
Other | Temperament as measured by the ATQ | Effortful Control Scale of the Adult Temperament Questionnaire: This 19-item self-report measure assesses several components of dispositional effortful control, including attentional control (i.e., ability to voluntarily focus or shift attention), inhibitory control (i.e., ability to inhibit behavior), and activation control (i.e., ability to activate behavior as needed). | 7 years post bariatric surgery | |
Other | Cognitive Control as measured by the Go/No-Go Task | Go/No-Go Task: This computerized task assesses the capacity for suppressing previously reinforced responses. | 7 years post bariatric surgery | |
Other | Cognitive Control as measured by the Delay Discounting Task | Delay Discounting Task: Delay discounting tasks require participants to choose between receiving a larger amount of money after a delay versus receiving a smaller amount immediately. | 7 years post bariatric surgery | |
Primary | Change in Psychopathology as measured by the SCID | Structured Clinical Interview for DSM-IV, Patients Edition (SCID) will be administered to assess comorbid Axis I psychopathology. | annually up to 7 years post bariatric surgery | |
Secondary | Change in Quality of life as measured by the IWQOL | Impact of Weight on Quality of Life Questionnaire: This is a 31-item, self-report, obesity-specific quality of life measure that will be utilized to assess quality of life. | annually up to 7 years post bariatric surgery | |
Secondary | Change in Quality of life as measured by the SF-36 | ShortForm-36: The SF-36 is a 36-item questionnaire that assesses functioning and quality of life as it relates to health status. | annually up to 7 years post bariatric surgery | |
Secondary | Change in Depression as measured by the BDI | Beck Depression Inventory: The BDI is a 21-item instrument that is widely used to assess depressive symptoms. | annually up to 7 years post bariatric surgery | |
Secondary | Change in Eating behaviors as measured by the EDE | Eating Disorder Examination: The diagnostic version of the EDE will be used as the primary measure of eating behavior and pathology. | annually up to 7 years post bariatric surgery | |
Secondary | Change in Impulse Control as measured by the SCID-ICD module | The impulse control module of the SCID will be administered to assess impulsive/compulsive disorders for participants. | annually up to 7 years post bariatric surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |